Anti-SLFN12L monoclonal antibody

Pre-made anti-SLFN12L monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLFN12L/SLFN12L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1750-Ab-1/ GM-Tg-hg-IP1750-Ab-2Anti-Human SLFN12L monoclonal antibodyHuman
GM-Tg-rg-IP1750-Ab-1/ GM-Tg-rg-IP1750-Ab-2Anti-Rat SLFN12L monoclonal antibodyRat
GM-Tg-mg-IP1750-Ab-1/ GM-Tg-mg-IP1750-Ab-2Anti-Mouse SLFN12L monoclonal antibodyMouse
GM-Tg-cynog-IP1750-Ab-1/ GM-Tg-cynog-IP1750-Ab-2Anti-Cynomolgus/ Rhesus macaque SLFN12L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1750-Ab-1/ GM-Tg-felg-IP1750-Ab-2Anti-Feline SLFN12L monoclonal antibodyFeline
GM-Tg-cang-IP1750-Ab-1/ GM-Tg-cang-IP1750-Ab-2Anti-Canine SLFN12L monoclonal antibodyCanine
GM-Tg-bovg-IP1750-Ab-1/ GM-Tg-bovg-IP1750-Ab-2Anti-Bovine SLFN12L monoclonal antibodyBovine
GM-Tg-equg-IP1750-Ab-1/ GM-Tg-equg-IP1750-Ab-2Anti-Equine SLFN12L monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1750-Ab-1/ GM-Tg-hg-IP1750-Ab-2; GM-Tg-rg-IP1750-Ab-1/ GM-Tg-rg-IP1750-Ab-2;
GM-Tg-mg-IP1750-Ab-1/ GM-Tg-mg-IP1750-Ab-2; GM-Tg-cynog-IP1750-Ab-1/ GM-Tg-cynog-IP1750-Ab-2;
GM-Tg-felg-IP1750-Ab-1/ GM-Tg-felg-IP1750-Ab-2; GM-Tg-cang-IP1750-Ab-1/ GM-Tg-cang-IP1750-Ab-2;
GM-Tg-bovg-IP1750-Ab-1/ GM-Tg-bovg-IP1750-Ab-2; GM-Tg-equg-IP1750-Ab-1/ GM-Tg-equg-IP1750-Ab-2
Products NameAnti-SLFN12L monoclonal antibody
Formatmab
Target NameSLFN12L
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLFN12L monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1750-Ag-1Recombinant multi-species SN12L/ SLFN12L protein


    Target information

    Target IDGM-IP1750
    Target NameSLFN12L
    Gene ID100506736,106992394
    Gene Symbol and SynonymsSLFN12L
    Uniprot AccessionQ6IEE8
    Uniprot Entry NameSN12L_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000205045
    Target ClassificationN/A

    The target: SLFN12L, gene name: SLFN12L, also named as . Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.